Maryland announces $238M in new opioid settlements with Walgreens, Walmart, two drugmakers

Maryland’s top lawyer announced Wednesday afternoon that the state had reached settlements with Walgreens, Walmart and two opioid manufacturers that are expected to add $238 million to its efforts to fight the opioid crisis over the course of 15 years. The settlements follow multi-year investigations of the roles of the opioid manufacturers and chain pharmacies in fueling Maryland’s opioid crisis, the Office of Maryland Attorney General Anthony G. Brown said in a news release.